drugset / Trial / NCT04398758
Moisturizer Mediated Prevention of Symptoms of Atopic Dermatitis in Early Childhood
Phase 3
Unknown
360 enrolled
Infectopharm Arzneimittel GmbH
Gesellschaft für Therapieforschung mbH · collab
RandomizedParallel-groupSingle-blindPrevention
Summary
In this study, it will be investigated if symptoms of atopic dermatitis of children with high familial risk will be delayed beyond the 6th or even 12th month of life by applying the SanaCutan Basiscreme.
Timeline
- Start
- 2020-07-22
- Primary completion
- 2023-12
- Completion
- 2024-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SanaCutan Basiscreme | Unknown | — | Topical |